RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FIANCHI L
Collezione AOU Alessandria

Items : 5

Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report. in American journal of hematology / Am J Hematol. 2025 Mar;100(3):358-374. doi: 10.1002/ajh.27565. Epub 2024 Dec 23.

2025
AOU Alessandria
AOU Città della Salute di Torino

D?browska-Iwanicka A; Brunetti SC; Drozd-Soko?owska J; van den Ven L; Fianchi L; Limongelli A; Sciumè M; Leotta D; Bavastro M; Musto P; Delia M; Wolf D; Anastasopoulou AN; Mayer J; Víšek B; Varricchio G; Arellano E; Córdoba R; Cerchione C; Prin R; Cvetanoski M; Mitrovi? M; Aiello TF; Glenthøj A; Gräfe SK; Schönlein M; Hersby DS; Adži?-Vuki?evi? T; Coppola N; et alii...

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry. in Haematologica / Haematologica. 2024 Aug 1;109(8):2693-2700. doi: 10.3324/haematol.2023.284678.

2024
AOU Alessandria
AOU San Luigi di Orbassano

Prin R; Wolf D; Arellano E; Ammatuna E; Nordlander A; Cabirta A; Cordoba R; Garcia-Bordallo D; Tragiannidis A; Rodrigues RN; Vehreschild M; Ra?il Z; Hanakova M; Lievin R; Mitrovic M; Garcia-Sanz R; Cvetanoski M; Varricchio G; Bahr NC; Emarah Z; De Ramon C; Meers S; Di Blasi R; Mendez GA; Pantic N; Stojanoski Z; Erben N; Groh A; Cattaneo C; et alii...

COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA). in Haematologica / Haematologica. 2023 Jan 1;108(1):22-33. doi: 10.3324/haematol.2022.280847.

2023
AOU Alessandria
AOU Città della Salute di Torino

Hoenigl M; Ammatuna E; Busca A; Corradini P; Rahimli L; Gräfe S; Khostelidi S; Martín-González JA; García-Poutón N; Sacchi MV; Rodrigues RN; Booth S; Sciumè M; Zambrotta G; Hanakova M; El-Ashwah S; Cordoba R; Calbacho M; Bahr NC; Cattaneo C; De Ramón-Sánchez C; Fazzi R; Glenthøj A; Sramek J; Kulasekararaj A; Jindra P; Navrátil M; Piedimonte M; Petzer V; et alii...

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.

2023
AOU Alessandria
ASL Città di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU Città della Salute di Torino

Della Porta MG; Santini V; Naldi I; Pasini P; Giordano L; Finelli C; Turrini M; Sancetta R; Selleri C; Tanasi I; Tosi P; Frigeni M; Marchetti M; Norata M; Grimaldi D; Fianchi L; Galimberti S; Ferrara F; Castelli A; Di Bona E; Di Veroli A; Bono R; Calvisi A; Rivoli G; Molteni A; Nicolino B; Occhini U; Leuzzi L; Genua A; et alii...

Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 May 1;39(13):1426-1436. doi: 10.1200/JCO.20.02619. Epub 2021 Mar 25.

2021
AOU Alessandria

Garcia-Manero G; Santini V; Almeida A; Platzbecker U; Jonasova A; Silverman LR; Falantes J; Reda G; Buccisano F; Fenaux P; Buckstein R; Diez Campelo M; Larsen S; Valcarcel D; Vyas P; Giai V; Olíva EN; Shortt J; Niederwieser D; Mittelman M; Fianchi L; La Torre I; Zhong J; Laille E; Lopes de Menezes D; Skikne B; Beach CL; Giagounidis A;